Form 4 for NAUT Nautilus Biotechnology, Inc.
Accepted 2022-06-28 00:00:00 ET · period of report 2022-06-27 · accession 0001808805-22-000075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-28 | 2022-06-27 | NAUT | Mowry Anna | CFO, Treas | P - Purchase | $2.75 | +5,500 | 39.2K | +16% | +$15.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-27 | P | A | 5,500 | $2.75 | 39,250 | D | — | — | (F1) Includes 1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan. |